Mimedx (MDXG) Cash & Equivalents (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82% |
| Dec 31, 2025 | 16.92% |
| Sep 30, 2025 | 19.53% |
| Jun 30, 2025 | 11.69% |
| Mar 31, 2025 | 1.93% |
| Dec 31, 2024 | 17.58% |
| Sep 30, 2024 | 28.63% |
| Jun 30, 2024 | 42.38% |
| Mar 31, 2024 | -40.87% |
| Jun 30, 2023 | 12.14% |
| Mar 31, 2023 | -7.17% |
| Dec 31, 2022 | -9.93% |
| Sep 30, 2022 | 0.99% |
| Jun 30, 2022 | -4.19% |
| Mar 31, 2022 | -13.10% |
| Dec 31, 2021 | -3.89% |
| Sep 30, 2021 | 6.59% |
| Jun 30, 2021 | 0.31% |
| Mar 31, 2021 | -11.55% |
| Dec 31, 2020 | -12.58% |
| Sep 30, 2020 | 127.38% |
| Jun 30, 2020 | -9.91% |
| Mar 31, 2020 | -22.54% |
| Dec 31, 2019 | -26.62% |
| Sep 30, 2019 | -2.87% |
| Jun 30, 2019 | 241.43% |
| Mar 31, 2019 | -37.10% |
| Dec 31, 2017 | -24.77% |
| Sep 30, 2017 | -23.16% |
| Jun 30, 2017 | 53.71% |
| Mar 31, 2017 | 1.99% |
| Dec 31, 2016 | 65.35% |
| Sep 30, 2016 | -22.96% |
| Jun 30, 2016 | 57.46% |
| Mar 31, 2016 | -42.52% |
| Dec 31, 2015 | -35.97% |
| Sep 30, 2015 | 6.40% |
| Jun 30, 2015 | -0.25% |
| Mar 31, 2015 | -16.93% |
| Dec 31, 2014 | -1.42% |
| Sep 30, 2014 | 20.40% |
| Jun 30, 2014 | -8.77% |
| Mar 31, 2014 | -2.40% |
| Dec 31, 2013 | 627.15% |
| Sep 30, 2013 | 44.55% |
| Jun 30, 2013 | -26.75% |
| Mar 31, 2013 | -15.23% |
| Dec 31, 2012 | -11.38% |
| Sep 30, 2012 | 187.08% |
| Jun 30, 2012 | -12.13% |
| Mar 31, 2012 | -26.54% |
| Dec 31, 2011 | 545.49% |
| Sep 30, 2011 | -60.53% |
| Jun 30, 2011 | 58.19% |
| Mar 31, 2011 | -23.89% |